1. BMC Med Genomics. 2020 Aug 17;13(1):113. doi: 10.1186/s12920-020-00764-3.

Clinical, genomics and networking analyses of a high-altitude native American 
Ecuadorian patient with congenital insensitivity to pain with anhidrosis: a case 
report.

López-Cortés A(1)(2), Zambrano AK(3), Guevara-Ramírez P(3), Echeverría BA(4), 
Guerrero S(3), Cabascango E(5), Pérez-Villa A(3), Armendáriz-Castillo I(3), 
García-Cárdenas JM(3), Yumiceba V(3), Pérez-M G(6), Leone PE(3), Paz-Y-Miño 
C(7).

Author information:
(1)Centro de Investigación Genética y Genómica. Facultad de Ciencias de la Salud 
Eugenio Espejo, Universidad UTE, Mariscal Sucre Avenue, 170129, Quito, Ecuador. 
aalc84@gmail.com.
(2)Latin American Network for Implementation and Validation of Clinical 
Pharmacogenomics Guidelines (RELIVAF-CYTED), Madrid, Spain. aalc84@gmail.com.
(3)Centro de Investigación Genética y Genómica. Facultad de Ciencias de la Salud 
Eugenio Espejo, Universidad UTE, Mariscal Sucre Avenue, 170129, Quito, Ecuador.
(4)Hospital San Luis de Otavalo, Ministerio de Salud Pública, Antonio José de 
Sucre Avenue, 100201, Otavalo, Ecuador.
(5)Sistemas Médicos (SIME), Universidad San Francisco de Quito, Interoceánica 
Avenue and Chimborazo, 170902, Cumbayá, Ecuador.
(6)Ministerio de Salud Pública, 100117, Ibarra, Ecuador.
(7)Centro de Investigación Genética y Genómica. Facultad de Ciencias de la Salud 
Eugenio Espejo, Universidad UTE, Mariscal Sucre Avenue, 170129, Quito, Ecuador. 
cesar.pazymino@ute.edu.ec.

BACKGROUND: Congenital insensitivity to pain with anhidrosis (CIPA) is an 
extremely rare autosomal recessive disorder characterized by insensitivity to 
pain, inability to sweat and intellectual disability. CIPA is caused by 
mutations in the neurotrophic tyrosine kinase receptor type 1 gene (NTRK1) that 
encodes the high-affinity receptor of nerve growth factor (NGF).
CASE PRESENTATION: Here, we present clinical and molecular findings in a 
9-year-old girl with CIPA. The high-altitude indigenous Ecuadorian patient 
presented several health problems such as anhidrosis, bone fractures, 
self-mutilation, osteochondroma, intellectual disability and Riga-Fede disease. 
After the mutational analysis of NTRK1, the patient showed a clearly autosomal 
recessive inheritance pattern with the pathogenic mutation rs763758904 (Arg602*) 
and the second missense mutation rs80356677 (Asp674Tyr). Additionally, the 
genomic analysis showed 69 pathogenic and/or likely pathogenic variants in 46 
genes possibly related to phenotypic heterogeneity, including the rs324420 
variant in the FAAH gene. The gene ontology enrichment analysis showed 28 
mutated genes involved in several biological processes. As a novel contribution, 
the protein-protein interaction network analysis showed that NTRK1, SPTBN2 and 
GRM6 interact with several proteins of the pain matrix involved in the response 
to stimulus and nervous system development.
CONCLUSIONS: This is the first study that associates clinical, genomics and 
networking analyses in a Native American patient with consanguinity background 
in order to better understand CIPA pathogenesis.

DOI: 10.1186/s12920-020-00764-3
PMCID: PMC7437939
PMID: 32807182 [Indexed for MEDLINE]

Conflict of interest statement: The authors declare no competing interests.